| |
RR
|
(95 % CI)
|
|---|
|
HIV status
| | |
|
Negative
|
Ref
| |
|
Positive
|
2.19
|
(2.03–2.37)
|
|
Unknown
|
1.86
|
(1.57–2.21)
|
|
Age group
| | |
|
15–24 years
|
Ref
| |
|
25–34 years
|
1.44
|
(1.28–1.63)
|
|
35–44 years
|
1.93
|
(1.70–2.18)
|
|
45–54 years
|
2.95
|
(2.64–3.30)
|
|
55–64 years
|
4.75
|
(4.12–5.48)
|
|
65+ years
|
9.16
|
(7.79–10.78)
|
|
Baseline smear
| | |
|
Negative
|
Ref
| |
|
Positive
|
0.88
|
(0.82–0.94)
|
|
No smear
|
1.25
|
(1.13–1.37)
|
|
Disease classification
| | |
|
PTB
|
Ref
| |
|
EPTB
|
1.14
|
(1.04–1.26)
|
|
Both
|
1.30
|
(1.10–1.55)
|
|
Gender
| | |
|
Female
|
Ref
| |
|
Male
|
1.06
|
(1.01–1.12)
|
|
Type of treatment
| | |
|
New
|
Ref
| |
|
Retreatment
|
1.34
|
(1.24–1.44)
|
|
Year
| | |
|
2009
|
Ref
| |
|
2010
|
0.92
|
(0.86–0.99)
|
|
2011
|
0.83
|
(0.76–0.90)
|
|
2012a
|
0.83
|
(0.74–0.93)
|
- RR relative risk, CI confidence interval, TB tuberculosis, PTB pulmonary TB, EPTB extra-pulmonary TB
- aOnly the first 6 months of 2012 were included in this analysis
